# Reversal of the Neurological Deficit in Acute Stroke With the Signal of Efficacy Trial of Auto BPAP to Limit Damage From Suspected Sleep Apnea

> **NCT01812993** · PHASE2 · UNKNOWN · sponsor: **Technische Universität Dresden** · enrollment: 60 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DEVICE:** Non-invasive ventilatory treatment with auto-BPAP

## Key facts

- **NCT ID:** NCT01812993
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01812993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01812993, "Reversal of the Neurological Deficit in Acute Stroke With the Signal of Efficacy Trial of Auto BPAP to Limit Damage From Suspected Sleep Apnea". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01812993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*